Atossa Therapeutics, Inc. Common Stock (ATOS) is a publicly traded Healthcare sector company. As of July 26, 2026, ATOS trades at $2.30 with a market cap of $22.89M and a P/E ratio of -0.57. ATOS moved -4.98% today. Year to date, ATOS is -74.07%; over the trailing twelve months it is -82.25%. Its 52-week range spans $1.70 to $19.65. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces ATOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover ATOS: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $16.00.
| Metric | Value |
|---|---|
| Price | $2.30 |
| Market Cap | $22.89M |
| P/E Ratio | -0.57 |
| EPS | $-4.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.65 |
| 52-Week Low | $1.70 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-34.77M |
| Gross Margin | 0.00% |
2 analysts cover ATOS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.